atrial-natriuretic-factor and Meconium-Aspiration-Syndrome

atrial-natriuretic-factor has been researched along with Meconium-Aspiration-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for atrial-natriuretic-factor and Meconium-Aspiration-Syndrome

ArticleYear
Endothelin-1, atrial natriuretic peptide and pathophysiology of pulmonary hypertension in porcine meconium aspiration.
    Acta paediatrica (Oslo, Norway : 1992), 1998, Volume: 87, Issue:4

    To evaluate the role of endothelin-1 (ET-1) and atrial natriuretic peptide (ANP) in the development of meconium aspiration-induced pulmonary hypertension, plasma ET-1 and ANP levels were measured serially for 6h after meconium instillation in juvenile pigs. Eleven 10-week-old, anaesthetized and catheterized pigs received intratracheally a bolus of 3 ml kg(-1) 20% human meconium, and five of them were premedicated with 30 mg kg(-1) methylprednisolone i.v. Another six pigs served as controls and were given 3 ml kg(-1) sterile saline intratracheally. Meconium instillation resulted in an increase in plasma ET-1 levels with a significant correlation to the simultaneously increasing PVR (r = 0.72). Methylprednisolone had no effect on the early (0-1 h) ET-1 increase, but prevented significantly the second phase (1-6 h) rise with a concomitant attenuation of the progressive pulmonary hypertension. ANP concentrations were higher in the meconium than in the control group throughout the study and further increased after steroid treatment with a good correlation to ET-1 (r = 0.86). Thus, the postinjury rise in circulating vasoactive peptides, together with the pulmonary hypertensive response, and modulation of the peptide balance and pressor reaction by steroids, suggest a contributory role for ET-1 and ANP in the development of pulmonary hypertension after meconium aspiration.

    Topics: Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Endothelin-1; Humans; Hypertension, Pulmonary; Infant, Newborn; Meconium Aspiration Syndrome; Methylprednisolone; Swine

1998
Relationship between plasma atrial natriuretic peptide concentrations and cardio-thoracic ratio during the early neonatal period.
    Acta paediatrica Scandinavica, 1989, Volume: 78, Issue:1

    Twenty-seven neonates were examined at 2.6 +/- 1.5 hours of age (stage 1) and 21 +/- 4.9 hours of age (stage 2) to clarify the relationship between cardio-thoracic ratio (CTR) on chest roentgenograms and plasma atrial natriuretic peptide (ANP) concentration. Among 22 infants who showed elevated plasma ANP, 14 had gained body weight (group A), while 8 other infants had lost weight (group B) at stage 2. The remaining 5 infants had decreased plasma ANP concentrations combined with weight loss at stage 2 (group C). All infants of group B had a patent ductus arteriosus. The plasma ANP concentration and CTR of groups A and B increased during the study period, while those of group C decreased. A linear relation was found between plasma ANP concentration and CTR in all cases (p less than 0.02). This study indicates that increased plasma levels of ANP are associated with an increased CTR.

    Topics: Atrial Natriuretic Factor; Female; Hemodynamics; Humans; Infant, Newborn; Male; Meconium Aspiration Syndrome; Respiration; Respiratory Distress Syndrome, Newborn

1989